Licensed Practical Nurse in Lynnwood, WA Accepting Medicare

9 Licensed Practical Nurse nurses found. Showing 1 - 9

Briana Caley Walsh, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2322 196th St Sw, Lynnwood, WA 98036 Phone: 254-984-0788

Phuong-thanh Thi Nguyen, RN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4807 196th St Sw, Suite 100, Lynnwood, WA 98036 Phone: 425-835-5850

Mr. Artur Vajushi, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 19723 48th Ave W, Apt G3, Lynnwood, WA 98036 Phone: 206-250-2109

Raina Amnatkeo, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2322 196th St Sw, Lynnwood, WA 98036 Phone: 425-984-0788

Ms. Cynthia June Bracy, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 15302 40th Ave W, 2-101, Lynnwood, WA 98087 Phone: 425-773-4892

Sherry Platt, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 20508 56th Ave W, Lynnwood, WA 98036 Phone: 425-678-1390

Adama Juwara, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 14014 Admiralty Way Apt 7c, Lynnwood, WA 98087 Phone: 586-277-7076

Jehna Anderson-evans, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2322 196th St Sw, Lynnwood, WA 98036 Phone: 971-678-0262

Shadae Heliodore, LVN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 14517 40th Ave W, Lynnwood, WA 98087 Phone: 860-313-9758

News Archive

Scientists identify biomarker associated with tamoxifen resistance in women with breast cancer

Scientists have identified a molecular 'flag' in women with breast cancer who do not respond or have become resistant to the hormone drug tamoxifen.

Decorative fountain in hospital linked to 2010 Wisconsin outbreak of Legionnaires' disease

A 2010 outbreak of Legionnaires' disease in Wisconsin has been linked to a decorative fountain in a hospital lobby, according to a study published in the February issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.

JumpStart Ventures announces investment commitment of $250,000 in ChanRx

JumpStart Ventures, which invests in and partners with innovative, early-stage companies in Northeast Ohio, announced an investment commitment of $250,000 in drug development company ChanRx. The two-year-old company is developing a pharmaceutical compound to treat atrial fibrillation, a heart condition that affects two million Americans, with 200,000 new cases being diagnosed each year.

FTC/TDF tablet reduces HIV infection among high-risk individuals: iPrEx study

In a finding with the potential to fundamentally change strategies to slow the global HIV epidemic, a new study called iPrEx shows that individuals at high risk for HIV infection who took a single daily tablet containing two widely used HIV medications, emtricitabine and tenofovir (FTC/TDF), experienced an average of 43.8% fewer HIV infections than those who received a placebo pill. New England Journal of Medicine, is the first evidence that this new HIV prevention method, called pre-exposure prophylaxis or PrEP, reduces HIV infection risk in people.

Read more Medical News

› Verified 4 days ago